The dominoes are starting to fall.
The Cannabist Co., one of the larger multi-state operators in U.S. cannabis, filed for bankruptcy protection in Delaware on March 25 — in what is believed to be the first attempt by a struggling cannabis firm to use the bankruptcy process rather than receivership to satisfy creditors. As Chris Roberts reported in MJBizDaily, the company has already sold off permits in Virginia, Ohio, and Delaware, surrendered its New York medical license, and is winding down Pennsylvania operations entirely. Even after those asset sales, Cannabist still owes approximately $270 million to lenders and the IRS.
Let that number sink in.
This isn't a story about one company making bad decisions. It's a story about what happens when an entire industry is forced to operate under federal illegality for long enough. Cannabis companies cannot access standard bankruptcy protections, cannot deduct ordinary business expenses under federal tax code Section 280E, and cannot access traditional banking at scale. They took on enormous debt loads to build multi-state footprints during the expansion era, and now that capital markets have tightened and lenders have run out of patience, there's nowhere left to go.
The Cannabist filing is notable because its Chapter 15 structure — reserved for foreign-incorporated entities — may not offer a meaningful blueprint for U.S.-incorporated cannabis companies facing similar pressure. Most struggling operators won't have the same path through federal bankruptcy court. Their options are narrower, and their outcomes could be worse.
The underlying problem hasn't changed: cannabis is still a Schedule I controlled substance at the federal level. SAFER Banking hasn't passed. 280E hasn't been reformed. Rescheduling to Schedule III, while in motion, doesn't resolve the fundamental issue of interstate commerce restrictions or banking access.
Until those structural problems get addressed, more operators — some of them names you'd recognize — are going to find themselves in the same position as Cannabist. Plenty of other MSOs are carrying significant debt loads with tightening cash flows and limited exit options.
This is what happens when an industry is told to operate like a business but treated like a controlled substance.
